Pulmonary vasculitis: update on the management of ANCA-associated vasculitis

U. Specks

Source: Eur Respir Mon; 2009: 46: 251–264
Disease area: Interstitial lung diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
U. Specks. Pulmonary vasculitis: update on the management of ANCA-associated vasculitis. Eur Respir Mon; 2009: 46: 251–264

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Pulmonary vasculitis
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019

Pulmonary vasculitis
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2018

Pulmonary vasculitis
Source: ERS Course 2016
Year: 2016

Pulmonary vasculitis
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019

Pulmonary manifestations of systemic vasculitis in childhood
Source: Breathe, 16 (4) 200211; 10.1183/20734735.0211-2020
Year: 2020

Sarcoidosis: pulmonary manifestations and management
Source: Eur Respir Monogr 2019; 86: 404-418
Year: 2019

Pulmonary haemorrhage and vasculitis in Graves’ disease
Source: Breathe 2008; 6: 169-174
Year: 2009

A rare association of pulmonary hemosiderosis with normocomplementemic urticarial vasculitis in a child
Source: Eur Respir J 2006; 28: Suppl. 50, 382s
Year: 2006

Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis
Source: Eur Respir J 2010; 36: 116-121
Year: 2010

Pulmonary manifestations of myeloperoxidase-antineutrophil cytoplasmic antibody(MPO-ANCA)-related systemic vasculitis:CT findings in 50 patients
Source: Eur Respir J 2002; 20: Suppl. 38, 267s
Year: 2002

Management of ANCA-associated vasculitis (AAV): A single-centre perspective from respiratory clinic.
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017

Early outcomes of patients with systemic lupus erythematosus and antiphospholipid syndrome after pulmonary endarterectomy
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016

Pulmonary involvement at presentation determines initial disease activity and permanent organ damage in ANCA-associated vasculitis
Source: Annual Congress 2007 - Imaging of pulmonary vascularisation and illustrated overview of lung pathology
Year: 2007

Diffuse alveolar hemorrhage and pulmonary fibrosis in MPO-ANCA-associated vasculitides
Source: Eur Respir J 2005; 26: Suppl. 49, 267s
Year: 2005

Systemic manifestations of sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 95s
Year: 2006

Radiologic finding of pulmonary vasculitis
Source: Annual Congress 2009 - Old and new: technique and pathology
Year: 2009

Interstitial lung disease with ANCA-associated vasculitis (AAV-ILD): Clinical features and survival compared to patients with ILD associated with systemic sclerosis and IPF
Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key
Year: 2020

Challenges in the management of patients with ANCA- associated vasculitides
Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Year: 2012

Granulomatous angiitis leading to a pulmonary veno-occlusive disease-like picture
Source: Eur Respir J 2009; 33: 666-669
Year: 2009

Pulmonary manifestations of systemic sclerosis, a report from Iran
Source: Annual Congress 2011 - Rare diffuse lung diseases
Year: 2011